Aktis Oncology, Inc. AKTS
Regular-session close
After hours · Nov 20, 4:01 PM ET
- YTD
- -27.90%
- 1 year
- -27.90%
Held by funds
61 US ETFs and mutual funds hold AKTS · largest positions
- VGHCX 0.07% of fund $28.47M
- VTI 0.00% of fund $16.62M
- IWM 0.02% of fund $11.87M
- NJM 0.01% of fund $9.31M
- XBI 0.08% of fund $8.77M
- FSSNX 0.02% of fund $6.02M
- VXF 0.01% of fund $5.71M
- SHSSX 0.08% of fund $5.19M
- VTWO 0.02% of fund $3.23M
- IWO 0.02% of fund $2.99M
- FSMAX 0.01% of fund $2.38M
- SCHA 0.01% of fund $2.20M
- NLO 0.01% of fund $1.68M
- NAJ 0.01% of fund $1.57M
- IWN 0.01% of fund $1.33M
- FSKAX 0.00% of fund $1.09M
- YALL 1.32% of fund $984.05K
- MDSKX 0.02% of fund $838.48K
- ITOT 0.00% of fund $563.60K
- FNCMX 0.00% of fund $556.26K
Ownership
- Institutions 73.0%
- Insiders 14.1%
- Public and other holders 12.9%
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| MPM Bioimpact LLC | 9.00% | 4,835,872 | 87.77M | Jun 29, 2026 |
| EcoR1 Capital, LLC | 8.98% | 4,824,469 | 87.56M | Jun 29, 2026 |
| Blue Owl Capital Holdings LP | 5.71% | 3,070,219 | 55.72M | Jun 29, 2026 |
| Blackrock Inc. | 4.24% | 2,278,358 | 41.35M | Jun 29, 2026 |
| T. Rowe Price Investment Management, Inc. | 3.82% | 2,051,447 | 37.23M | Jun 29, 2026 |
| Wellington Management Group, LLP | 3.66% | 1,966,244 | 35.69M | Jun 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 2.72% | 1,462,244 | 26.54M | Jul 30, 2026 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 1.26% | 676,577 | 12.28M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.09% | 585,135 | 10.62M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 1.01% | 542,593 | 9.85M | Aug 30, 2026 |
| MUTUAL FUND SERIES TRUST-Eventide Healthcare & Life Sciences Fund | 0.94% | 507,000 | 9.20M | Jun 29, 2026 |
| T. Rowe Price Eqy. Fd.s, Inc.-T. Rowe Price Inst. Small-Cap Stock Fd. | 0.67% | 358,947 | 6.51M | Jun 29, 2026 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Leadership team
Who runs AKTS, and what each was last paid
Matthew Roden, President, CEO & DirectorAverage age 55
| Name | Title | Pay | Age |
|---|---|---|---|
| Matthew Roden | President, CEO & Director | $915K | — |
| Akos Czibere | Chief Medical Officer | $677K | 48 |
| Paul L. Feldman | Chief Scientific Officer | $642K | 64 |
| Shulamit Ron-Bigger | Chief Operating Officer | $537K | 45 |
| Kyle D. Kuvalanka | Chief Financial Officer | — | 58 |
| Carlos Rodriguez | Executive Director of Corporate Development | — | — |
| Todd Foley | Co-Founder & Chairman | — | 54 |
| Patrick A. Baeuerle | Co-Founder & Member of Scientific Advisory Board | — | 68 |
| Tyler Benedum | Chief Technical Officer | — | 49 |
| Dasa Lipovsek | VP & Head of Lead Discovery | — | — |
Pay is the latest total FMP has for each person (salary, bonus, stock and other awards) and can lag the newest proxy statement. Source: Financial Modeling Prep, from the company’s SEC filings.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CZIBERE AKOS M.D. | Officer | Sale | Sep 22, 2026 | 0 |
| ECOR1 CAPITAL, L.L.C. | Unknown | Purchase | Jan 11, 2026 | 0 |
| FOLEY TODD | Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Jan 11, 2026 | 0 |
| GADICKE ANSBERT S. | Beneficial Owner of more than 10% of a Class of Security | Purchase | Jan 11, 2026 | 0 |
| HERRMANN KEN M.D. | Director | Sale | Jul 19, 2026 | 0 |
| KIM HELEN SUSAN | Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Jan 11, 2026 | 0 |
